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Objective
In the present study, we validated a set of variables that
predict the presence of a mutation in one of the 3 genes
known to be associated with the common monogenic
autoinflammatory diseases.
Methods
A total of 93 consecutive patients with a clinical history
of periodic fever were screened for mutations in the
MVK, TNFRSF1A, and MEFV genes, and detailed clinical
information was collected prospectively. For autosomal-
recessive diseases (MKD and FMF), only homozygous or
compound heterozygous patients were accepted as
genetically positive. The developed diagnostic score was
validated in an independent set of 93 patients.
Results
93 patients whose suspected diagnosis was one of the
autoinflammatory diseases were enrolled. The mean age
at onset was 58,64+40,69 months (54 F, 39 M;). A total of
25 patients with periodic or recurrent fevers did not dis-
play any mutation in the 3 genes examined. Of these 68
patients with positive findings on genetic testing, 30 of
them had a mutation only in one allele and 38 had muta-
tions in two alleles for MEFV gene. In addition, we iden-
tified 4 low-penetrance R92Q mutations for TRAPS and
3 patients, who were compound heterozygotes for the
MVK gene. The diagnostic score revealed moderate sen-
sitivity (68%) and specificity (58%) for discriminating
patients who were genetically positive from those who
were negative.
Conclusion
The suggested set of variables may be used to decide on
genetic screening for patients with periodic fever syn-
dromes. However, further studies are needed to improve
the sensitivity of the suggested score.
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